Literature DB >> 34368906

Low vitamin D levels in follicular fluid, but not in serum, are associated with adverse outcomes in assisted reproduction.

Kahindo P Muyayalo1,2, Su Song3, Hui Zhai4, Hong Liu1, Dong-Hui Huang1, Hui Zhou1, Yang-Jiao Chen3, Ai-Hua Liao5.   

Abstract

PURPOSE: To assess the relationship between serum/follicular fluid (FF) vitamin D (VD) status and assisted reproductive technology (ART) treatment outcomes among infertile patients.
METHODS: A prospective cohort study, including 132 infertile patients scheduled for their first ART treatment cycle, was carried out in a Reproductive Medical Center. Serum and FF samples were collected to assess 25-hydroxy VD [25(OH)D] levels. Low VD level was defined as 25(OH)D concentration of less than 30 ng/mL.
RESULTS: Most infertile patients had low VD levels in serum (88%) and FF (90%). We observed a moderately positive correlation between VD levels in serum and FF (r = 0.34, p < 0.0001). Compared to the group of patients with low VD levels in the FF, those with sufficient VD levels had a significantly higher number of retrieved oocytes (p = 0.03), normal fertilization (p = 0.01), and high-quality embryos (p = 0.001). Moreover, patients with sufficient VD levels in the FF also had significantly higher implantation rates than those with low VD levels (76.92% vs. 46.58%, respectively, p = 0.01) and clinical pregnancy rates (92.31% vs. 61.54%, respectively, p = 0.04).
CONCLUSION: These data collectively revealed that low VD levels in serum and FF were common among infertile patients. VD levels in FF, but not in serum, were associated with embryo quality, normal fertilization, implantation rates, and clinical pregnancy rates. Further studies are mandatory to determine the molecular mechanism and VD's potential therapeutic benefits in infertile patients.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Assisted reproduction outcomes; Assisted reproductive technology; Follicular fluid; Infertility; Vitamin D

Mesh:

Substances:

Year:  2021        PMID: 34368906     DOI: 10.1007/s00404-021-06174-9

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  61 in total

1.  Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-controlled study.

Authors:  Antonino Lasco; Antonino Catalano; Salvatore Benvenga
Journal:  Arch Intern Med       Date:  2012-02-27

2.  Effect of vitamin D3 treatment on glucose metabolism and menstrual frequency in polycystic ovary syndrome women: a pilot study.

Authors:  E Wehr; T R Pieber; B Obermayer-Pietsch
Journal:  J Endocrinol Invest       Date:  2011-05-24       Impact factor: 4.256

3.  Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells.

Authors:  Hongling Du; Gaurang S Daftary; Sasmira I Lalwani; Hugh S Taylor
Journal:  Mol Endocrinol       Date:  2005-05-19

4.  Vitamin D improves endometrial thickness in PCOS women who need intrauterine insemination: a randomized double-blind placebo-controlled trial.

Authors:  Mojgan Asadi; Nasim Matin; Mitra Frootan; Jaleh Mohamadpour; Mostafa Qorbani; Fatemeh Davari Tanha
Journal:  Arch Gynecol Obstet       Date:  2013-10-26       Impact factor: 2.344

Review 5.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.

Authors:  Sylvia Christakos; Puneet Dhawan; Annemieke Verstuyf; Lieve Verlinden; Geert Carmeliet
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

Review 6.  Role of vitamin D in ovarian physiology and its implication in reproduction: a systematic review.

Authors:  Mohamad Irani; Zaher Merhi
Journal:  Fertil Steril       Date:  2014-06-03       Impact factor: 7.329

7.  Polymorphisms in vitamin D-related genes and risk of uterine leiomyomata.

Authors:  Lauren A Wise; Edward A Ruiz-Narváez; Stephen A Haddad; Lynn Rosenberg; Julie R Palmer
Journal:  Fertil Steril       Date:  2014-06-02       Impact factor: 7.329

8.  Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages.

Authors:  M Di Rosa; G Malaguarnera; C De Gregorio; M Palumbo; G Nunnari; L Malaguarnera
Journal:  Cell Immunol       Date:  2012-11-29       Impact factor: 4.868

Review 9.  Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators.

Authors:  Evelyne Van Etten; Brigitte Decallonne; Lieve Verlinden; Annemieke Verstuyf; Roger Bouillon; Chantal Mathieu
Journal:  J Cell Biochem       Date:  2003-02-01       Impact factor: 4.429

10.  Vitamin D: The "sunshine" vitamin.

Authors:  Rathish Nair; Arun Maseeh
Journal:  J Pharmacol Pharmacother       Date:  2012-04
View more
  1 in total

Review 1.  Calcifediol (25OHD) Deficiency and Its Treatment in Women's Health and Fertility.

Authors:  Ana Arnanz; Juan A Garcia-Velasco; José Luis Neyro
Journal:  Nutrients       Date:  2022-04-27       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.